N-乙酰半胱氨酸在血栓性血小板减少性紫癜小鼠和狒狒临床前模型中的作用
本研究在小鼠和狒狒模型中评估N-乙酰半胱氨酸(NAC)预防和缓解血栓性血小板减少性紫癜(TTP)的效果。小鼠预防性给予NAC可有效预防严重TTP体征,但小鼠和狒狒中NAC均不能缓解已存在的TTP体征,即使观察到VWF多聚体减少。
要点
- 小鼠预防性给予NAC可有效预防严重TTP体征。
- NAC在体外可减少VWF多聚体。
- NAC不能逆转小鼠和狒狒已存在的TTP体征。
核心结论
- 小鼠中预防性给予NAC(不联用血浆置换)可有效预防严重TTP体征,但NAC不能缓解小鼠和狒狒已存在的急性TTP体征。
研究设计与样本
- 研究使用成熟的小鼠和狒狒TTP模型,评估NAC在不联用血浆置换和免疫抑制治疗时预防和缓解TTP体征的效果。
主要发现
- 小鼠中预防性给予NAC有效预防严重TTP体征。
- 体外数据显示NAC在溶液中具有减少VWF多聚体的特性。
- 小鼠和狒狒中给予NAC未能缓解已存在的TTP体征,血小板减少、溶血性贫血和器官损伤未能逆转,血栓未溶解。
- 尽管观察到循环VWF多聚体减少,NAC未能改善临床结局。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Thrombotic thrombocytopenic purpura (TTP) is a microangiopathic disorder diagnosed by thrombocytopenia and hemolytic anemia, associated with a deficiency in von Willebrand factor (VWF)-cleaving protease ADAMTS13. Current treatment is based on plasma infusion for congenital TTP, or plasma exchange, often in combination with immunosuppressive agents, for acquired TTP. These treatment methods are not always effective; therefore, new treatment methods are highly necessary. N-acetylcysteine (NAC), an FDA-approved anti-mucolytic agent, is a possible new treatment strategy for TTP, as it was demonstrated to reduce disulfide bonds in VWF, thereby decreasing VWF multimers size and hence their prothrombotic potential. We investigated whether NAC, without concurrent plasma exchange and immunosuppressive therapy, is effective in preventing and resolving TTP signs, using well-established murine and baboon models for TTP. In mice, prophylactic administration of NAC was effective in preventing severe TTP signs. This in vivo finding was supported by in vitro data demonstrating the VWF multimer-reducing properties of NAC in solution. Nonetheless, in both mice and baboons, administration of NAC was not effective in resolving preexisting TTP signs; thrombocytopenia, hemolytic anemia, and organ damage could not be reversed, as thrombus resolution was not achieved. Failure to improve clinical outcome occurred even though a reduction in VWF multimers was observed, demonstrating that NAC was efficient in reducing disulfide bonds in circulating VWF multimers. In conclusion, prophylactic administration of NAC, without concurrent plasma exchange, was effective in preventing severe TTP signs in mice, but NAC was not effective in resolving preexistent acute TTP signs in mice and baboons.
引用
- Tersteeg C, Roodt J, Van Rensburg WJ, et al. N-acetylcysteine in preclinical mouse and baboon models of thrombotic thrombocytopenic purpura. Blood. 2016. PMID: 28011677. doi:10.1182/blood-2016-09-738856
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。